Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 3
1982 1
1983 2
1984 1
1985 2
1986 5
1987 3
1988 2
1989 3
1990 4
1991 4
1992 7
1993 7
1994 7
1995 4
1996 3
1997 6
1998 5
1999 4
2000 3
2001 10
2002 8
2003 20
2004 23
2005 19
2006 24
2007 22
2008 31
2009 31
2010 44
2011 76
2012 87
2013 114
2014 140
2015 166
2016 168
2017 187
2018 226
2019 218
2020 241
2021 332
2022 403
2023 406
2024 496
2025 549
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,666 results

Results by year

Filters applied: . Clear all
Page 1
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients.
Zhong L, Gan L, Wang B, Wu T, Yao F, Gong W, Peng H, Deng Z, Xiao G, Liu X, Na J, Xia D, Yu X, Zhang Z, Xiang B, Huo Y, Yan D, Dong Z, Fang F, Ma Y, Jin G, Su D, Liu X, Li Q, Liao H, Tang C, He J, Tang Z, Zhang S, Qiu B, Yang Z, Yang L, Chen Z, Zeng M, Feng R, Jiao J, Liao Y, Wang T, Wu L, Mi Z, Liu Z, Shi S, Zhang K, Shi W, Zhao Y. Zhong L, et al. Among authors: feng r. Cell. 2025 Feb 20;188(4):1119-1136.e23. doi: 10.1016/j.cell.2024.12.010. Epub 2025 Jan 17. Cell. 2025. PMID: 39826543 Free article.
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).
Sharman JP, Munir T, Grosicki S, Roeker LE, Burke JM, Chen CI, Grzasko N, Follows G, Mátrai Z, Sanna A, Qiu L, Feng R, Hua VM, Jurczak W, Ritgen M, Yi S, Bosch F, Coombs CC, Bao K, Patel V, Liu B, Compte L, Guntur A, Wang DY, Hill M, Leow CC, Ghia P, Barr PM. Sharman JP, et al. Among authors: feng r. J Clin Oncol. 2025 Aug;43(22):2538-2549. doi: 10.1200/JCO-25-00166. Epub 2025 Jun 6. J Clin Oncol. 2025. PMID: 40479620 Free PMC article. Clinical Trial.
Synergistic effects of LCN2 and TWEAK on the progression of psoriasis.
Ren K, Peng X, Duan X, Feng R, Cook C, Lu M, Li M, Gu H, Wang X, Deng G, Ma H, Liu Y, Xia Y. Ren K, et al. Among authors: feng r. Cell Mol Immunol. 2025 Jul;22(7):760-775. doi: 10.1038/s41423-025-01292-9. Epub 2025 May 15. Cell Mol Immunol. 2025. PMID: 40369189 Free PMC article.
Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction.
Abdellatif M, Vasques-Nóvoa F, Trummer-Herbst V, Durand S, Koser F, Islam M, Nah J, Sung EA, Feng R, Aprahamian F, Prokesch A, Zardoya-Laguardia P, Sadoshima J, Diwan A, Linke WA, Ferreira JP, Kroemer G, Sedej S. Abdellatif M, et al. Among authors: feng r. Eur Heart J. 2025 May 14;46(19):1863-1866. doi: 10.1093/eurheartj/ehaf062. Eur Heart J. 2025. PMID: 39995248 Free PMC article. No abstract available.
Taste impairment in patients with Parkinsonism.
Zhu Q, Liu H, Wang J, Feng R, Ma M, Wang X, Ding X. Zhu Q, et al. Among authors: feng r. J Neurol. 2025 Mar 1;272(3):238. doi: 10.1007/s00415-025-12983-8. J Neurol. 2025. PMID: 40024924 Free PMC article.
3,666 results